TREATMENT OF WILSONS-DISEASE

被引:7
作者
DEISS, A [1 ]
机构
[1] UNIV UTAH, SCH MED, SALT LAKE CITY, UT 84112 USA
关键词
D O I
10.7326/0003-4819-99-3-398
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:398 / 400
页数:3
相关论文
共 13 条
[1]   ORAL ZINC THERAPY FOR WILSONS-DISEASE [J].
BREWER, GJ ;
HILL, GM ;
PRASAD, AS ;
COSSACK, ZT ;
RABBANI, P .
ANNALS OF INTERNAL MEDICINE, 1983, 99 (03) :314-320
[2]   DIAGNOSIS OF TREATABLE WILSON DISEASE [J].
CARTWRIGHT, GE .
NEW ENGLAND JOURNAL OF MEDICINE, 1978, 298 (24) :1347-1350
[3]   GENETIC EXPRESSION OF WILSONS-DISEASE IN CELL-CULTURE - A DIAGNOSTIC MARKER [J].
CHAN, WY ;
CUSHING, W ;
COFFMAN, MA ;
RENNERT, OM .
SCIENCE, 1980, 208 (4441) :299-300
[4]   THE EFFECTS OF BAL IN HEPATOLENTICULAR DEGENERATION [J].
CUMINGS, JN .
BRAIN, 1951, 74 (01) :10-22
[5]   THE COPPER AND IRON CONTENT OF BRAIN AND LIVER IN THE NORMAL AND IN HEPATO-LENTICULAR DEGENERATION [J].
CUMINGS, JN .
BRAIN, 1948, 71 (04) :410-415
[6]   THE EFFECT OF BAL (2,3-DIMERCAPTOPROPANOL) ON HEPATOLENTICULAR DEGENERATION (WILSONS DISEASE) [J].
DENNYBROWN, D ;
PORTER, H .
NEW ENGLAND JOURNAL OF MEDICINE, 1951, 245 (24) :917-925
[7]  
EPSTEIN O, 1980, GASTROENTEROLOGY, V78, P1442
[8]   ORAL ZINC-SULFATE AS LONG-TERM TREATMENT IN WILSONS DISEASE (HEPATOLENTICULAR DEGENERATION) [J].
HOOGENRAAD, TU ;
KOEVOET, R ;
DERUYTERKORVER, EGWM .
EUROPEAN NEUROLOGY, 1979, 18 (03) :205-211
[9]  
SCHEINBERG IH, 1982, LANCET, V1, P1469
[10]   A COMPARISON OF COPPER-LOADING DISEASE IN BEDLINGTON TERRIERS AND WILSONS-DISEASE IN HUMANS [J].
SU, LC ;
RAVANSHAD, S ;
OWEN, CA ;
MCCALL, JT ;
ZOLLMAN, PE ;
HARDY, RM .
AMERICAN JOURNAL OF PHYSIOLOGY, 1982, 243 (03) :G226-G230